Table 3.
Guidelines | Class of Recommendation | Level of Evidence |
---|---|---|
Pre-EXCEL and NOBLE | ||
2014 ESC/EACTS55 | I: LMCA disease with a SYNTAX score of ≤22 IIa: LMCA disease with a SYNTAX score of 23–32 III: LMCA disease with a SYNTAX score of ≥33 |
B |
2014 ACC/AHA57 | IIa: For SIHD patients when both of the following are present:
|
B B B |
Post-EXCEL and NOBLE | ||
2018 ESC/EACTS56 | I: LMCA disease with a SYNTAX score of ≤22 IIa: LMCA disease with a SYNTAX score of 23–32 III: LMCA disease with a SYNTAX score of ≥33 |
A |
2021 ACC/AHA58 | IIa: In selected patients with SIHD and significant LMCA disease for whom PCI can provide equivalent revascularization to that possible with CABG, PCI is reasonable to improve survival. | B |